1073 AZD5863, a CLDN18.2 and CD3 Binding T-cell Engager, Establishes a Multi-Faceted Antitumour Immune Response and Combines Effectively with Chemo-Immunotherapy Regimens
Regular and Young Investigator Award Abstracts(2024)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要